{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:20:58Z","timestamp":1790079658285,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Union's Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"name":"Bodelschwingh Scholarship"},{"DOI":"10.13039\/501100003099","name":"FAZIT-Stiftung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003099","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neuropharm.2015.03.014","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T19:34:35Z","timestamp":1428262475000},"page":"234-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy"],"prefix":"10.1016","volume":"95","author":[{"given":"Friederike","family":"Twele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Bankstahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"R\u00f6mermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.03.014_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0306-4522(91)90159-L","article-title":"The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration","volume":"42","author":"Andersson","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0306-4522(98)00401-1","article-title":"Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy","volume":"89","author":"Bouilleret","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1523\/JNEUROSCI.10-01-00311.1990","article-title":"Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia","volume":"10","author":"Buchan","year":"1990","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1742-7843.2009.00403.x","article-title":"Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus","volume":"104","author":"Cunha","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0090-9556(25)08371-0","article-title":"Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid","volume":"22","author":"Dalgaard","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0920-1211(94)90016-7","article-title":"The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures","volume":"17","author":"D\u00fcrm\u00fcller","year":"1994","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib8","first-page":"573","article-title":"Failure of folic acid derivatives to mimic the actions of kainic acid in brain in\u00a0vitro or in\u00a0vivo","volume":"4","author":"Ferkany","year":"1982","journal-title":"Neurobehav. Toxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib9","series-title":"Antiepileptic Drugs","first-page":"341","article-title":"Antiepileptic drug development program","author":"Gladding","year":"1985"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1528-1157.2003.03603.x","article-title":"Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy","volume":"44","author":"Gouder","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2007.06.021","article-title":"Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice","volume":"207","author":"Gr\u00f6ticke","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.expneurol.2008.04.036","article-title":"Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate","volume":"213","author":"Gr\u00f6ticke","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1684\/epd.2012.0528","article-title":"Animal models to study aetiopathology of epilepsy: what are the features to model?","volume":"14","author":"Guillemain","year":"2012","journal-title":"Epileptic. Disord."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib14","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","article-title":"Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy","volume":"52","author":"Hanada","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2014.891580","article-title":"The discovery and development of perampanel for the treatment of epilepsy","volume":"9","author":"Hanada","year":"2014","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2005.11.044","article-title":"Effect of YM872, a selective and highly water-soluble AMPA receptor antagonist, in the rat kindling and rekindling model of epilepsy","volume":"531","author":"Hara","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2011.01.001","article-title":"Increase in BDNF-mediated TrkB signaling promotes epileptogenesis in a mouse model of mesial temporal lobe epilepsy","volume":"42","author":"Heinrich","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1528-1157.1999.tb00845.x","article-title":"Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures","volume":"40","author":"Hort","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib19","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.eplepsyres.2014.10.002","article-title":"Low doses of ethanol markedly potentiate the anticonvulsant effect of diazepam in a mouse model of difficult-to-treat focal seizures","volume":"108","author":"Klein","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuropharm.2014.11.008","article-title":"Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice","volume":"90","author":"Klein","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(99)00295-2","article-title":"Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat","volume":"374","author":"Kodama","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.nbd.2009.12.002","article-title":"Kindling as a model of temporal lobe epilepsy induces bilateral changes in spontaneous striatal activity","volume":"37","author":"K\u00fccker","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.neuropharm.2011.06.015","article-title":"Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats","volume":"61","author":"Langer","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib24","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/epi.12378","article-title":"AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures","volume":"54","author":"Lippman-Bell","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1460-9568.1993.tb00224.x","article-title":"Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy","volume":"5","author":"L\u00f6scher","year":"1993","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib27","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/0014-2999(94)90514-2","article-title":"Over-additive anticonvulsant effect of memantine and NBQX in kindled rats","volume":"259","author":"L\u00f6scher","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0920-1211(94)90012-4","article-title":"Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?","volume":"17","author":"L\u00f6scher","year":"1994","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0301-0082(97)00092-0","article-title":"Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy","volume":"54","author":"L\u00f6scher","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib30","series-title":"Ionotropic Glutamate Receptors as Therapeutic Target","first-page":"91","article-title":"Epilepsy","author":"L\u00f6scher","year":"2002"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib31","series-title":"Models of Seizures and Epilepsy","first-page":"551","article-title":"Animal models of drug-refractory epilepsy","author":"L\u00f6scher","year":"2006"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research","volume":"62","author":"L\u00f6scher","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneurol.2012.222","article-title":"Epilepsy: perampanel-new promise for refractory epilepsy?","volume":"8","author":"L\u00f6scher","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib34","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for antiepileptic drug discovery and development","volume":"12","author":"L\u00f6scher","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.neuropharm.2015.03.014_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1167.2012.03610.x","article-title":"Hippocampal sclerosis\u2013origins and imaging","volume":"53","author":"Malmgren","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","article-title":"Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice","volume":"8","author":"Maroso","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib37","first-page":"S14","article-title":"The role of glutamate in epilepsy and other CNS disorders","volume":"44","author":"Meldrum","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0006-8993(94)90630-0","article-title":"Antiepileptogenic and anticonvulsant effects of Nbqx, a selective Ampa receptor antagonist, in the Rat Kindling Model of Epilepsy","volume":"638","author":"Namba","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib39","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1528-1157.1998.tb01268.x","article-title":"Antiepileptic drugs as a cause of worsening seizures","volume":"39","author":"Perucca","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eplepsyres.2006.12.004","article-title":"Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat","volume":"74","author":"Pitk\u00e4nen","year":"2007","journal-title":"Epilepsy Res."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2015.03.014_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yebeh.2008.09.023","article-title":"Molecular and cellular basis of epileptogenesis in symptomatic epilepsy","volume":"14","author":"Pitk\u00e4nen","year":"2009","journal-title":"Epilepsy Behav."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.neuropharm.2015.03.014_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1528-1167.2010.02602.x","article-title":"Therapeutic approaches to epileptogenesis \u2013 hope on the horizon","volume":"51","author":"Pitk\u00e4nen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(10)70310-0","article-title":"Mechanisms of epileptogenesis and potential treatment targets","volume":"10","author":"Pitk\u00e4nen","year":"2011","journal-title":"Lancet Neurol."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.neuropharm.2015.03.014_bib45","first-page":"R790","article-title":"Combination of non-NMDA and glycine\/NMDA antagonism: anticonvulsant effect in the kindling model of epilepsy","volume":"358","author":"Potschka","year":"1998","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ana.10085","article-title":"Phenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus","volume":"51","author":"Prasad","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation: II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroenceph. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib48","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1523\/JNEUROSCI.1734-08.2008","article-title":"Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures","volume":"28","author":"Rakhade","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuropharm.2010.11.005","article-title":"Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats","volume":"60","author":"Rattka","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0306-4522(02)00064-7","article-title":"Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy","volume":"112","author":"Riban","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib51","first-page":"947","article-title":"AMPA receptors in epilepsy and as targets for antiepileptic drugs","volume":"79","author":"Rogawski","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0028-3908(00)00112-X","article-title":"Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse","volume":"40","author":"Rogawski","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ane.12100","article-title":"Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist","author":"Rogawski","year":"2013","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ane.12099","article-title":"AMPA receptors as a molecular target in epilepsy therapy","author":"Rogawski","year":"2013","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2015.03.014_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/epi.12504","article-title":"Adverse effects and safety profile of perampanel: a review of pooled data","volume":"55","author":"Rugg-Gunn","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0306-4522(94)00463-F","article-title":"Morphogenetic effect of kainate on adult hippocampal neurons associated with a prolonged expression of brain-derived neurotrophic factor","volume":"64","author":"Suzuki","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.0013-9580.2005.35504.x","article-title":"Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy","volume":"46","author":"Suzuki","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.03.014_bib58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/ejn.12424","article-title":"Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy","volume":"39","author":"T\u00f6pfer","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.03.014_bib59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/jcbfm.1991.110","article-title":"Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil. J Cereb","volume":"11","author":"Warner","year":"1991","journal-title":"Blood Flow Metab."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815001069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815001069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:37:19Z","timestamp":1747867039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815001069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":59,"alternative-id":["S0028390815001069"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.03.014","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}